Updated:
Yantai Zhenghai Investment
Zhenghai emphasizes value-oriented investment and has established Zhenghai Investment, Zhenghai Jianwu and other investment platforms. These platforms enable...
Yantai Zhenghai Investment
Zhenghai emphasizes value-oriented investment and has established Zhenghai Investment, Zhenghai Jianwu and other investment platforms. These platforms enable it to invest globally and cover all investment business types, constructing a bridge between capital and industry.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Yantai
Corporate office
Yantai, China
Sector focus
Frequently asked questions
Which sectors does Yantai Zhenghai Investment target?
The firm's investment focus aligns with the parent group's core manufacturing and technology competencies: rare-earth permanent magnets, new-energy vehicle drivetrains, regenerative medicine, automotive interiors, and electronic information systems. This translates into a portfolio oriented around advanced manufacturing, energy transition, healthcare, and industrial technology — sectors where the group's subsidiary operations can provide post-investment operational support.
What investment stages and instruments does the firm use?
Yantai Zhenghai Investment pursues a multi-stage mandate that includes early-stage venture capital, growth equity, and PIPE (private investment in public equity) transactions. This range allows it to back companies from seed-stage innovation through pre-IPO or listed-company stakes, often in sectors where the parent group possesses deep technical expertise.
How does the parent group's technology base influence investment decisions?
With over 450 authorized patents, participation in China's national 863 Program, and seven high-tech enterprise-designated subsidiaries, Zhenghai Group offers its investment arm a proprietary technical evaluation capability. Portfolio companies can access sibling-manufacturing lines for prototyping and testing, creating a sourcing and value-creation advantage that pure financial sponsors cannot replicate.
Are there publicly listed entities within the group relevant to the investment arm?
Yes. Two subsidiaries are listed on China's ChiNext board: one focused on rare-earth permanent magnetic materials, the other on regenerative biomedicine. These listed units operate independently, but their technology pipelines and market knowledge inform the investment arm's sector-specific thesis development and deal evaluation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: